Trial Profile
Study for the establishment of conditioning regimen in cord blood transplantation for children: To evaluate feasibility and effectiveness of cord blood transplantation using the conditioning regimen including Fludarabine phosphate for children with acute leukemia.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Fludarabine (Primary) ; Cyclophosphamide
- Indications Leukaemia
- Focus Therapeutic Use
- 20 Apr 2011 Status changed from recruiting to discontinued as reported by University Hospital Medical Information Network - Japan record.
- 08 Jun 2009 New trial record.